MENU
OCT 22, 2020 11:00 AM EDT

Impact of Segmentation Quality on Assay Endpoints - Deep Learning for High Content Screening

Speaker

Abstract

As High Content Analysis (HCA) has matured and gained wider adoption as a quantitative research tool, the application space has grown and is no longer limited to a finite list of well defined assays performed in standard biological models. To account for this added complexity, a large focus has been placed on improving the flexibility and performance of analysis methods. Machine Learning is becoming ubiquitous and there are many examples these methods outperforming traditional methods for applications across many industries, scientific disciplines, and every day life. One would assume that technologies such as Deep Learning could provide similar benefits in HCA. But with any new technology, one has to weigh the potential benefits against the associated costs of adoption. We will present background information describing some of the fundamental differences between image analysis methods, considerations one should keep in mind when evaluating analysis methods, and some examples suggesting the improvements one could realize by employing technologies such as Deep Learning.

Learning Objectives

  • Limitations of image processing methods and the advantages of machine learning for object segmentation
  • Survey of machine learning approaches and key differences with respect to their application in HCA
  • The impact of improved segmentation accuracy on the overall endpoint of High Content screens

Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
Loading Comments...
Show Resources